80 likes | 91 Views
The Centralised Result Management Bureau is a transformative system that centralizes and automates the management of healthcare test results. With close oversight and granular reporting, it has significantly reduced costs, improved treatment rates, and increased screening and testing in primary care and community pharmacy settings. However, further work is needed to validate outcomes and ensure structural support for long-term success.
E N D
Centralised Result Management Bureau Merle Symonds, Lead Health Adviser Leni Edmonds, Results Administrator
Some Context • Four legacy organisations • 3 Acute NHS Trusts • 1 PCT • 4 GUM Services • 1 CASH Service • 1 Chlamydia Screening Programme • Variation in: • Systems, automation and turnaround times • Resource associated with results management • PN processes and reported KPIs (0.1 - 0.6)
Process • Single networked information system • Centralised management team • Centralised diary management • Automated results management system (99.8% TAT <72hrs) • Close oversight and process management • Granular reporting of PN / Real time reporting
Outcomes • £118,000 reduction associated staffing costs • Reduction in sampling incidents (avg 5 datix reports per month) • 85% of all results management managed on an automated basis (>800,000 tests per annum). • Treatment rates (CT and GC – 99.7%)
Outcomes • PN outcomes (2015/16) • CT – 1.05 (HCW verified 0.61) • GC – 0.88 (HCW verified 0.55) • Retest rates (CT) 37% • Reinfection rate (CT) 7% • 29% growth in DRI between 2013-15
Primary Care Support • Significant transformation of primary care sexual health (integrating the NCSP, guidance for commissioners, DH 2012) • General Practice • Cessation of NCSP forms • GPs manage all aspect of pathway • Monthly failsafe to assure Rx and option for PN support • Community Pharmacy • 46 Services on LES (EHC, HIV, CT/GC testing/Rx and epidemiological Rx) • Results management team notify and initiate PN.
Primary Care • Outcomes • 60% growth in GP screening in past 3 years • 400% growth in Pharmacy screening in past 18 months • Limitations • GP – Limited ability to qualify PN activity or measure meaningful outcomes • Pharmacy – Significant support required to mobilise and support pharmacy • Issues re: assuring safeguarding
Key Points • Centralised, interoperable systems are key • Limited utility in absence of a skilled workforce • Measuring and verifying PN is pivotal • However further work required to validate outcomes. • Commissioning of services needs to consider structural support (training, governance, quality assurance) alongside cost